- Robert Crisci will become Vice President and Chief Financial Officer. Mr. Crisci is currently Vice President, Finance and Investor Relations.
- Jason Conley will become Vice President and Controller. Mr. Conley is currently Senior Vice President, Finance and Human Resources of Managed Health Care Associates, a Roper subsidiary.
- Neil Hunn and Paul Soni will become Executive Vice Presidents. Mr. Hunn is currently a Group Vice President. Mr. Soni is currently Vice President and Controller.
Neil Hunn has been a Group Vice President with Roper Technologies' medical segment since 2011 and has helped drive the growth in the Company's medical technology and application software businesses. Prior to joining Roper, Mr. Hunn served 10 years as Executive Vice President and CFO at MedAssets, an Atlanta-based SaaS company, and as President of its revenue cycle technology businesses. He successfully led MedAssets' initial public offering and the execution of several M&A transactions. Mr. Hunn earned his MBA from Harvard Business School and his bachelor's degree in finance and accounting from Miami University (Ohio).Paul Soni joined Roper in 2002 as Director of Accounting and assumed his current role in 2006. Prior to joining Roper, Mr. Soni, served four years as Controller for Oxford Industries, Inc., an international apparel company, and four years as Controller of the International Division of Savannah Foods & Industries, Inc. Earlier in his career, Mr. Soni was with Price Waterhouse LLP for eight years where he performed audit and transaction support services. Mr. Soni received a bachelor's degree in accounting from Georgia Southern University and is a CPA and CMA. Robert Crisci joined Roper in 2013 as Vice President, Finance and Investor Relations and has led the Company's financial planning and analysis and investor relations activities. Prior to joining Roper, he served in various roles across investment banking, consulting and finance. His prior experience includes positions at Morgan Keegan, VRA Partners, Devon Value Advisers and Deloitte & Touche. Mr. Crisci holds an MBA from Columbia Business School and an AB in Economics from Princeton University. Jason Conley joined Roper in 2006 as head of financial planning and analysis and investor relations. He assumed his current role as Senior Vice President of Finance and Human Resources at the Company's Managed Health Care Associates subsidiary in 2013. Mr. Conley earlier served in roles of increasing responsibility at Honeywell International and Deloitte. He received an MBA from the Kellogg School of Management at Northwestern University and a BA from the University of Washington, and is a CPA.
About Roper TechnologiesRoper Technologies is a constituent of the S&P 500, Fortune 1000, and the Russell 1000 indices. Roper designs and develops software (both software-as-a-service and licensed), and engineered products and solutions for healthcare, transportation, food, energy, water, education and other niche markets worldwide. Additional information about Roper is available on the Company's website at www.ropertech.com. The information provided in this press release contains forward-looking statements within the meaning of the federal securities laws. These forward-looking statements may include, among others, statements regarding operating results, the success of our internal operating plans, and the prospects for newly acquired businesses to be integrated and contribute to future growth, profit and cash flow expectations. Forward-looking statements may be indicated by words or phrases such as "anticipate," "estimate," "plans," "expects," "projects," "should," "will," "believes," "intends" and similar words and phrases. These statements reflect management's current beliefs and are not guarantees of future performance. They involve risks and uncertainties that could cause actual results to differ materially from those contained in any forward-looking statement. Such risks and uncertainties include our ability to integrate acquisitions and realize expected synergies. We also face other general risks, including our ability to realize cost savings from our operating initiatives, general economic conditions, changes in foreign exchange rates, difficulties associated with exports, risks associated with our international operations, difficulties in making and integrating acquisitions, risks associated with newly acquired businesses, increased product liability and insurance costs, increased warranty exposure, future competition, changes in the supply of, or price for, parts and components, environmental compliance costs and liabilities, risks and cost associated with asbestos related litigation, potential write-offs of our substantial intangible assets, and risks associated with obtaining governmental approvals and maintaining regulatory compliance for new and existing products. Important risks may be discussed in current and subsequent filings with the SEC. You should not place undue reliance on any forward-looking statements. These statements speak only as of the date they are made, and we undertake no obligation to update publicly any of them in light of new information or future events.
Contact Information:Investor Relations941firstname.lastname@example.org